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ABSTRACT 
Objective: To explore whether Human T-cell leukemia virus type I (HTLV-I) 
directly infects salivary gland epithelial cells (SGECs) and induces the niche of 
Sjögren’s syndrome (SS). 
Methods: We determined the inflammation-related molecules profiles after the 
co-culture of SGECs with HTLV-I, producing the CD4+ T-cell line HCT-5 or 
Jurkat by antibody dot-blot array, immunofluorescence (IF) and ELISA. The 
apoptosis-related molecules profile was determined by antibody dot-blot array 
and IF. We investigated the presence of HTLV-I-related molecules by IF and in 
situ PCR. The apoptosis of SGECs was evaluated by TUNEL staining. 
Results: 7.8 ± 1.3 % of the SGECs were positive for HTLV-I-related proteins 
after 96-h co-culture with HCT-5 cells. Nuclear expression of NF-κB p65 also 
became positive in 10% of the SGECs. The presence of HTLV-I proviral DNA in 
SGECs after co-culture with HCT-5 cells was detected by in situ PCR. A 
semiquantitative analysis by dot-blot antibody array in co-cultured supernatant 
with HCT-5 showed time-dependent increases of cytokines and chemokines 
including sICAM-1, RANTES, and interferon γ-induced protein 10 kDa 
(IP-10/CXCL10), confirmed by IF and ELISA. The expressions of pro-apoptotic 
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molecules (e.g., cytochrome C and Fas) and anti-apoptotic molecules [e.g., Bcl-2, 
Heme oxygenase-2 (HO-2) and HSP-27] were increased in the SGECs 
co-cultured with HCT-5, showing that apoptosis of SGECs was not detected after 
co-culture with HCT-5 or Jurkat. 
Conclusion: HTLV-I is thought to infect SGECs and alter their cellular functions. 
These changes may induce the niche of SS and contribute to the development of 
SS found in anti-HTLV-I antibody-positive subjects. 
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INTRODUCTION 
Human T-cell leukemia virus type I (HTLV-I) is reported to be one of the 
causative agents of primary Sjögren’s syndrome (pSS) in endemic areas 
including Nagasaki City, Japan (1–3). The extremely high prevalence of SS 
found in patients with HTLV-I-associated myelopathy (HAM) appears to confirm 
a strong relationship between HTLV-I infection and SS (4–6). Our previous study 
also revealed the clinical characteristics of anti-HTLV-I antibody-positive SS 
patients, and we found that the labial salivary glands (LSGs) of such patients are 
not destructible compared to the LSGs of anti-HTLV-I antibody-negative SS 
patients (7). In addition, the low appearance of ectopic germinal center (GC) as 
well as the low expression of C-X-C motif chemokine 13 (CXCL13) in 
infiltrating mononuclear cells of LSGs were found as an immunohistological 
characteristic of anti-HTLV-I antibody-positive SS patients (8). 
HTLV-I preferentially infects T cells, especially CD4+ T cells, and our 
findings described above indicated that the T-cell lineage may primarily 
contribute to the pathogenesis of anti-HTLV-I antibody-positive SS patients. 
However, the cell types other than T cells, including the human retinal pigment 
epithelial cell line ARPE-19 (9) and human primary fibroblast-like synovial cells 
H. Nakamura et al. 6 
(FLS) (10) were reported to be susceptible to HTLV-I infection. In ARPE-19 
cells, the expression of intercellular adhesion molecule 1 (ICAM-1) is increased 
by HTLV-I, and the production of granulocyte/macrophage colony-stimulating 
factor (GM-CSF) from FLS is induced by HTLV-I. 
These observations suggested that HTLV-I may infect cell lineages other 
than T cells of human salivary glands and may contribute to the development of 
SS. In this regard, ductal epithelial cells are considered candidate cells, since 
varying cytokines, chemokines and apoptosis-related molecules have been shown 
to be expressed in these cells (1). In addition, ductal epithelial cells attract T cells 
into the salivary glands of SS patients through the production of an 
interferon-gamma (IFN-γ)-inducible 10-kDa protein (IP-10) and a monokine 
induced by IFN-γ (Mig) (11). 
Here we investigated whether HTLV-I infects human primary salivary 
gland epithelial cells (SGECs) and modulates the production of functional 
molecules. 
 
PATIENTS AND METHODS 
Patients 
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Primary SGECs from LSGs were obtained from fifteen patients with primary SS 
diagnosed according to the revised criteria proposed by the American-European 
Consensus Group (12). All fifteen patients were female (age: 53.2 ± 15.4) in 
whom anti-HTLV-I antibody measured by a chemiluminescent enzyme 
immunoassay (CLEIA) was negative. 
 
Antibodies and reagents 
Mouse anti-HTLV-I (p19, p28, and GAG) antibody (Chemicon International, 
Temecula, CA, USA), mouse anti-NF-κB p65 antibody, mouse anti-cytochrome 
C antibody, mouse anti-HSP-27 antibody, rabbit anti-Fas antibody and rabbit 
anti-Fas antibody (Santa Cruz Biotechnology, Santa Cruz, CA) were obtained. 
Mouse anti-heme oxygenase 2 (HO-2) antibody was purchased from OriGene 
Technologies (Rockville, MD), and rabbit anti-ICAM-1 antibody, rabbit 
anti-GRO/CXCL-1 antibody, anti-CCL5/RANTES antibody and rabbit 
anti-IP-10/CXCL10 antibody were purchased from LifeSpan Biosciences (Seattle, 
WA). Rabbit anti-IL-8 antibody was purchased from Abgend (San Diego, CA). 
Secondary antibodies including donkey anti-mouse IgG conjugated with 
fluorescein isothiocyanate (FITC) and donkey anti-rabbit IgG conjugated with 
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tetramethyl rhodamine isothiocyanate (TRITC) were purchased from Jackson 
ImmunoResearch Laboratories (West Grove, PA). Hoechst dye 33258 was 
purchased from Sigma (St. Louis, MO). Proteome Profiler™, the human cytokine 
array panel A array kit, the human apoptosis array kit, and the Quantikine® 
ELISA for sICAM-1, CXCL10/IP-10, CCR5/RANTES, CXCL1/GROα and 
CXCL8/IL-8 was purchased from R&D Systems (Minneapolis, MN). Amersham 
Cy3-dUTP was purchased from GE Healthcare (Buckinghamshire, UK). 
Monoclonal mouse anti-human CD4, CD8, CD20cy, mouse IgG1 and 
monoclonal rabbit anti-human cytokeratin 8/18 antibody were purchased from 
Dako Cytomation (Glostrup, Denmark). 
 
LSGs biopsy and cell culture 
We performed a biopsy of the LSGs from each patient’s lower lip under local 
anesthesia and divided the samples into specimens for the diagnosis of 
sialadenitis by hematoxylin staining and the culture of SGECs in a defined 
keratinocyte–serum-free medium (SFM) culture medium (Invitrogen Life 
Technologies, Carlsbad, CA) supplemented with hydrocortisone (Sigma) and 
bovine pituitary extract (Kurabo, Osaka, Japan). All nine patients were 
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compatible with the diagnosis of SS in the classification of Chisholm & Mason 
(13). 
For the co-culture of SGECs with HTLV-I-producing T cells, we 
co-cultured the cell line HCT-5, which is derived from cerebrospinal fluid cells of 
a patient with HAM (14) with SGECs during the designated time period in the 
defined keratinocyte-SFM culture medium. As a control toward HCT-5, 
non-HTLV-I infected T cell line Jurkat was cultured in RPMI 1640 medium with 
10% fetal bovine serum. For below experiments, HCT-5 or Jurkat cells were 
co-cultured with SGECs at 2:1 ratio when the cells were seeded. Briefly, the 
SGECs were seeded on sterile cover slips for immunofluorescence. Then, HCT-5 
cells were added 24 hr after SGECs stuck and grew on cover slips. For 
immunofluorescence, cells were stringently washed with PBS to remove 
remaining HCT-5 cells. Informed consent for the usage of LSGs biopsy samples 
was obtained from all nine patients at the commencement of the study. The study 
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We performed the immunofluorescence studies as described (15). Briefly, 
SGECs cultured on 12-mm2 cover slips were fixed in phosphate-buffered saline 
(PBS) containing 4% paraformaldehyde at 4°C, followed by immersion in 
methanol at −20°C for 10 min. After fixation, the SGECs were blocked in 5% 
normal horse serum in PBS, and then incubated in the primary antibodies for 1 h 
at room temperature followed by incubation with FITC-conjugated and 
TRITC-conjugated secondary antibodies with Hoechst dye 33258 under dark 
conditions. The SGECs were then mounted in Vectashield mounting medium 
(Vector Laboratories, Burlingame, CA) and scanned by fluorescence microscopy 
(BIOREVO BZ-9000, Keyence, Osaka, Japan). For the measurement of the 
immunofluorescence of the HCT-5 cells, fixed cells were incubated with mouse 
monoclonal primary antibodies as cell surface markers, followed by 
FITC-conjugated secondary antibody and Hoechst dye 33258. Control 
experiments were performed to confirm the isotype specificity of the secondary 
antibodies. Immunostaining of HCT-5 cells was performed in the same manner 
as that described above for SGECs. 
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Terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling 
(TUNEL) staining 
To investigate double-stranded DNA breaks of SGECs, we used TUNEL staining 
as described in our previous study (16). After fixation, SGECs were incubated in 
4% paraformaldehyde (PFA) 4°C for 15 min, followed by immersion in PBS 
with 0.5% Tween 20 and 0.2% bovine serum albumin using the MEBSTAIN 
Apoptosis kit Direct (MBL, Nagoya, Japan). The SGECs were then incubated 
with a 50-µL terminal deoxynucleotidyl transferase (TdT) solution at 37°C for 1 
h. The FITC signal of dUTP was captured by fluorescence microscopy using the 
BIOREVO BZ-9000. For positive control to show induction of apoptosis, tumor 
necrosis factor-related apoptosis inducing ligand (TRAIL) (15). 
 
Cytokine dot-blot array analysis for co-cultured supernatant 
We used a cytokine dot-blot array system used according to the manufacturer’s 
instructions (Proteome Profiler™, the human cytokine array panel A array kit, 
R&D Systems, Minneapolis, MN). Briefly, we incubated diluted co-cultured 
supernatant with a cocktail of biotinylated antibodies for 1 h after the membranes 
were blocked. The mixture of cytokines/chemokines and antibodies was then 
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incubated for 2 h with this array system, which was combined with an 
immobilized antibody on the membrane. For the detection of cytokines and 
chemokines, chemiluminescent reagents were used after incubation with 
streptavidin-horseradish peroxidase. The expressions are noted as the ratio 
compared with control dot-blots. 
 
Apoptosis dot-blot array analysis for co-cultured lysate 
We used an apoptosis dot-blot array system used according to the manufacturer’s 
instructions (Proteome Profiler™, the human apoptosis array kit, R&D Systems, 
Minneapolis, MN). Briefly, diluted co-cultured cellular extracts were incubated 
on membranes for 2 h after the membranes were blocked for 1 h. After a 2-h 
incubation, a cocktail of biotinylated antibodies was added to the membranes and 
incubated for 1 h. Chemiluminescent reagents were then used after incubation 
with streptavidin-horseradish peroxidase for 30 min. The expressions are noted 
as the ratio compared with control dot-blots. 
 
Cytokine and chemokine assay for co-cultured supernatant by ELISA 
The ELISA system was used according to the manufacturer’s instructions, and 
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the levels of sICAM-1, CXCL10/IP-10, CCR5/RANTES, CXCL1/GROα and 
CXCL8/IL-8 were measured (all from R&D Systems). Briefly, the assigned 
volume of the cell culture supernatant, standard or control was added to an 
ELISA well and incubated for the indicated times. After the wells were washed 
and decanted three times, each conjugate was added to a well and incubated for 1 
h at 4°C. After the washing process, substrate solution was added to each well 
and incubated for 15 min. After the addition of stop solution, optical density at 
450 nm was measured. 
 
In situ PCR of HTLV-I proviral DNA in the co-cultured SGECs 
Initially, SGECs co-cultured with or without HCT-5 were fixed in 0.5 mL 
Carnoy’s fixative for 20 min at room temperature, followed by washing with 0.5 
mL 70% ethanol for 15 min at room temperature on type I collagen-coated 
12-mm2 cover slips. After treatment with pre-warmed protein kinase (PK) (1 
µg/mL) at 37°C for 15 min and three washes with PBS, the SGECs were fixed 
with 4% PFA/PBS for 5 min, then immersed in 50% formamide/2× saline sodium 
citrate buffer (SSC) at 4°C overnight. After being washed with 
deuterium-depleted water (DDW) three times for 5 min each time, the cells were 
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mixed with an amplification cocktail that consisted of a final concentration of 1× 
PCR buffer, 1 µg/mL of forward primer (5’-CGGATACCCAGTCTACGTGT-3’), 
1 µg/mL of reverse primer (5’-GAGCCGATAACGCGTCC-3’) (17), 0.2 mM 
dNTP, 2.5 mM MgCl2, 1 µM Cy3-dUTP and distilled water without DNA 
polymerase, and then boiled for 10 min. 
The application of these primer sets had been reported by Matsuoka et al., 
in which the positions of the forward primer and reverse primer were 7358–7377 
and 7516–7494 of the HTLV-I pX region, respectively (17). After KAPA2G 
FastDNA polymerase (Kapa Biosystems, Woburn, MA) complete amplification 
cocktail was added to the SGECs and sealed with clear rubber covers, we placed 
the cover slips in a thermocycler for an in situ PCR (Hybaid Limited, Ashford, 
Middlesex, UK). The details of the in situ PCR reaction were as follows: each 
block was heated at 92°C for 3 min, and then five cycles of PCR were performed 
(92°C, 1 min; 47°C, 1 min; 70°C, 2 min), and the block was then held at 70°C for 
5 min. The reacted cover slips were then washed with 2×SSC at 37°C for 15 min, 
four times, followed by washing with 0.5×SSC at 45°C for 15 min, two times. 
After the cover slips were reacted with PBS once and covered with Vectashield 
mounting medium, we visualized the SGECs by the fluorochrome with the 
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fluorescence microscope (BIOREVO BZ-9000). 
 
Statistical analysis 
Differences in the ELISA results were analyzed using Student’s t-test. P-values 
<0.05 were accepted as significant. 
 
RESULTS 
The phenotype and viability of HCT-5 cells 
We found that the HCT-5 cells used for co-culture with SGECs showed the CD4+ 
phenotype (Fig. 1A) without staining for CD8 and CD20. The HCT-5 cells were 
viable with translocation of NF-κB into the nucleus in co-culture medium (i.e., 
the defined keratinocyte-SFM) for SGECs for 0–96 h (Fig. 1B). 
 
Detection of HTLV-I-related proteins in SGECs during co-culture 
After the co-culture of SGECs and HCT-5 cells, immunofluorescence 
demonstrated the clear signals of HTLV-I proteins p19, p28 and GAG emerged at 
72–96 h (Fig. 2A). In the low-magnification view at 96h co-culture of SGECs 
with HCT-5 cells, approx. 10% of the SGECs showed HTLV-I-positive staining 
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(Fig. 2B). Nuclear NF-κB p65 was also detected among 10% of the SGECs after 
co-culture (Fig. 2A, B). To distinguish HTLV-I-infected SGECs from HCT-5, 
SGECs were stained with cytokeratin 8/18 (Fig. 2C) that was reported to be one 
of markers for SGECs (18). In merged view, frequency of HTLV-I-infected 
SGECs was calculated as 7.8 ± 1.3 % and the remaining HCT-5 cells were 
observed during 48-96 h co-culture. 
 
Detection of HTLV-I DNA in SGECs by in situ PCR 
To investigate the details and confirm whether HTLV-I infected the SGECs 
during co-culture with HCT-5 cells, we determined the HTLV-I DNA expression. 
For a positive control, HTLV-I proviral DNA was detected in HCT-5 cells (Fig. 
3A). During the co-culture, amplified HTLV-I DNA was observed in the nucleus 
of SGECs in the presence of primer at 48 h of co-culture with HCT-5 cells (Fig. 
3B). The strongest HTLV-I DNA signal was observed at 72 h of co-culture in the 
presence of primer. 
 
Increased expression of inflammation-related molecules and 
apoptosis-related molecules in the co-cultured SGECs 
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The cytokine dot-blot array results for the HCT-5/SGECs co-cultured supernatant 
shown in Figure 4A. The expressions of GM-CSF, CXCL1/GROα, CCL1, 
sICAM-1, IL-1ra, IL-6, IL-8, CXCL10/IP-10, MIF, Serpin E1 and 
CCR5/RANTES were increased time-dependently after the co-culture of SGECs 
with HCT-5. 
The results of the apoptosis dot-blot array from SGECs lysate co-cultures 
with HCT-5 are shown in Figure 4B. Pro-apoptotic molecules including 
pro-caspase-3, cytochrome C and Fas in the lysate showed slightly increased 
responses after the co-culture of SGECs with HCT-5 cells. The signals of 
anti-apoptotic molecules including Bcl-2, HO-2, HSP-27 or SMAC/Diablo were 
also up-regulated after the co-culture.  
Dot-blot array results to indicate co-culture of SGECs with Jurkat were shown in 
Figure 4C and 4D. The expressions of IL-1ra, MIF and Serpin E1 were increased 
after the co-culture of SGECs with Jurkat, however, the increase was not 
time-dependently (Fig. 4C). Different from co-culture with HCT-5, expressions 
of other molecules including GM-CSF, CXCL1/GROα, CCL1, sICAM-1, IL-6, 
IL-8 and CXCL10/IP-10 were not increased. The results of the apoptosis dot-blot 
array from SGECs lysate co-cultures with Jurkat are shown in Figure 4D. 
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Although expressions of pro-caspase-3 and SMAC/Diablo were similar to 
HCT-5/SGECs co-culture results, expressions of cytochrome C, Fas, Bcl-2, HO-2 
and HSP-27 were not up-regulated after the co-culture with Jurkat.  
The dot-blot data were confirmed by immunofluorescence and ELISA. 
As shown in Figure 5A, the immunofluorescence results showed the increased 
cytoplasmic expressions of ICAM-1, CXCL1, RANTES, IL-8 and IP-10 with 
augmentation of the signals for HTLV-I p19, p28 and GAG in SGECs (See 
spindle-shaped SGECs stained positive with both inflammatory molecules with 
GAG) after 96 h co-culture with HCT-5 cells. However, expressions of these 
molecules were not increased when SGECs were co-cultured with Jurkat (Fig. 
5B). Accordingly, significant increases of sICAM-1, RANTES, and IP-10 in the 
co-cultured supernatant compared to before the co-culture was confirmed by 
ELISA (Fig. 5C). However, in SGECs/Jurkat co-culture supernatant, significant 
increase of sICAM-1, RANTES, and IP-10 was not observed (Fig. 5D). 
Furthermore, these molecules as well as IL-8 were barely detected in 
SGECs/Jurkat co-culture supernatant. The immunofluorescence results of 
apoptosis-related molecules also showed that the membranous expression of Fas 
on SGECs as well as the cytoplasmic expressions of Bcl-2, cytochrome C, HO-2 
H. Nakamura et al. 19 
and HSP-27 were up-regulated after 96-h co-culture with HCT-5 (Fig. 6A). By 
comparison with  results from HCT-5/SGECs co-culture, no increase of 
apoptosis-related molecules was observed on SGECs co-cultured with Jurkat 
(Fig. 6B).  
 
Detection of no apoptosis of co-cultured SGECs 
We have reported that cultured SGECs are committed to apoptosis by several 
stimuli (15, 16). Since in the present study we found that the expression of 
pro-apoptotic molecules was increased by co-culture with HCT-5 cells, it could 
be speculated that the co-culture with HCT-5 cells might induce apoptosis of 
SGECs. As we showed previously, the SGECs stimulated with TRAIL showed 
clear increases of TUNEL-positive cells (Fig. 6C, positive control). In contrast, 
during the 0 to 96 h co-culture, no TUNEL-positive staining was observed in the 
SGECs during co-culture with HCT-5 cells (Fig. 6C).  In addition, no obvious 
morphological change was observed on the bright field views during co-culture. 
Similarly, no TUNEL positive staining was observed in the SGECs during the 0 
to 96 h co-culture with Jurkat (Fig. 6D). 
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DISCUSSION 
With regard to the relationship between pSS and retrovirus, Talal et al. first 
reported that serum antibodies against human immunodeficiency virus (HIV)-1 
were detected in 30% of sera from patients with pSS (19), and the presence of 
retroviral particles was reported in salivary tissues from patients with SS (20). 
The retroviral particles were also found in LSGs from patients with SS (21). 
Regarding HTLV-I infection in pSS, Mariette et al. reported the presence 
of HTLV-I tax gene in LSGs from pSS patients, although LSGs from patients 
with other inflammatory diseases also contained this gene, suggesting that 
HTLV-I tax gene contributes to the development of chronic inflammatory 
diseases including pSS (22, 23). In addition, Green et al. showed that HTLV-I tax 
transgenic mice exhibited exocrinopathy involving the salivary glands, and tax 
protein was detected in their salivary glands and muscle specimens (24). 
A recent report showed that HTLV-I p19 or Tax proteins were expressed 
in 42.4% of LSG samples from the patients with SS, and the clinical 
characteristics of these SS patients (including low levels of complement and high 
lymphocyte counts) were identified (25). Considering the above accumulating 
evidence of relationship between HTLV-I and SS, we speculate that HTLV-I may 
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directly infect SGECs, a major cellular constituent of the salivary glands, and 
change their characteristics to an inflammatory phenotype, triggering the 
development of SS. 
In the present study we observed for the first time that HTLV-I appears to 
infect SGECs, although the expression of HTLV-I-related protein was less than 
10% among co-cultured SGECs. The migration of HTLV-I into SGECs was 
suggested to induce functional alterations of SGECs, since some of the SGECs 
became positive for nuclear NF-κB p65, which is known as a representative 
transcriptional factor activated by HTLV-I (26). Accordingly, the production of 
several inflammatory cytokines and chemokines was increased during the 
co-culture of SGECs with HCT-5 cells in the present study. However, regarding 
the above alterations of SGECs, one or more pathways other than the direct 
infection of HTLV-I in SGECs may be used, since a substantial population of 
SGECs after co-culture was not stained by HTLV-I related proteins, HTLV-I 
proviral DNA or nuclear NF-κB p65. Autocrine or paracrine interactions of 
cytokines and chemokines might be involved in these processes, in which the 
cytokines and chemokines induce the production of the others (27). Alternatively, 
transcriptional factors or activators other than NF-κB p65, such as cyclic AMP 
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response element-binding protein/activating transcription factor (CREB/ATF) 
and CREB-binding protein, which serves as a transcription activator, might be 
essential (28, 29). Whether unique changes induced by HCT-5 are consequences 
due to direct infection of HTLV-I toward SGECs or indirect effect of the 
molecules, produced by neighboring activated cells including HCT-5, is a crucial 
issue. In the co-culture, SGECs look like spindle-shaped and intensity of GAG 
staining is not as strong as that of HCT-5 cells observed in Fig. 1B, suggesting 
SGECs appear to be distinguishable from HCT-5. Some SGECs became double 
positive with GAG and inflammatory molecules in the co-culture (Fig. 5A at 96 
hr). Since the co-culture of SGECs with non-HTLV-I infected T cell line Jurkat 
did not induce the changes of expression of functional molecules as compared 
with HCT-5, cell-free HTLV-I virions might conduce the changes of SGECs. 
Although no evidence of cell free transmission of HTLV-I toward any of 
epithelial cells has been reported, HTLV-I virions have potential to infect 
myeloid and plasmacytoid dendritic cells (DCs) (30). Previous study also showed 
intercellular adhesion molecule-3-grabbing nonintegrin related to DCs plays an 
important role in cell-free infection of HTLV-I toward DCs (31). Further studies 
trying to show cell free infection of HTLV-I virions toward SGECs are needed in 
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the future. 
In addition to inflammatory cytokines and chemokines, pro-apoptotic 
molecules as well as anti-apoptotic molecules were augmented in the SGECs 
after co-culture with HCT-5 cells by comparison with co-culture with Jurkat in 
our study. However, we should also note that apoptosis dot array results might be 
influenced by the remaining HCT-5 cells during co-culture. As we demonstrated 
in Fig. 2C, HCT-5 cells stick to SGECs during co-culture and approximately 5% 
of HCT-5 cells still remained at 96h. The reason why HCT-5 cells remained in 
co-cultured is speculated that these cells had migratory and adhesive capacity as 
we previously reported that CD4-positive T cells derived from HAM patients 
showed strong transmigrating activity (32).  
The increase in these molecules may be induced through the activation of 
transcriptional factors including NF-κB p65 or the cytokines and chemokines 
produced by SGECs themselves. It has been demonstrated that the expressions of 
both pro-apoptotic molecules and anti-apoptotic molecules are regulated by the 
above mechanisms (33, 34). Increases in the expression of anti-apoptotic 
molecules such as Bcl-2, HO-2 and HSP-27 might antagonize the 
apoptosis-inducing capacities of Fas and cytochrome C of SGECs, indicating that 
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apoptosis does not occur in SGECs. 
It is interesting to note that the HTLV-I infection of SGECs induces the 
niche of SS, since the expression pattern of cytokines, chemokines, pro-apoptotic 
molecules, and anti-apoptotic molecules of SGECs co-cultured with HCT-5 cells 
in vitro resembles the pattern found in vivo in the salivary glands of SS patients 
(35). However, it may be disputed whether the present in vitro results truly reflect 
in vivo observations of patients with anti-HTLV-I antibody-positive SS. In this 
regard, Ohyama et al. (36) reported that in LSGs from patients with HTLV-I 
antibody-positive SS, HTLV-I proviral DNA was observed not in acinar or ductal 
epithelial cells of LSGs, but in the infiltrating T lymphocytes by in situ PCR 
hybridization (36).  
It has become evident that CD4+ T cells infected by HTLV-I resemble 
FoxP3+ regulatory T cells (37). Regulatory T cells produce regulatory cytokines 
such as IL-10 and transforming growth factor (TGF)-β1 (38), which might affect 
the migration of HTLV-I into ductal epithelial cells in vivo. Further studies are 
necessary to clarify the differences and similarities of the in vitro role of HTLV-I 
infection and the in vivo role of HTLV-I infection observed in patients with SS. 
In summary, we have shown the direct infection of HTLV-I in human 
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primary SGECs that induces the niche of the salivary glands of patients with SS. 
In addition to the recent report from South Korea (24), our clinical and 
histological examinations have also revealed the characteristics of anti-HTLV-I 
antibody-positive SS patients, including the low rate of ectopic germinal center 
formation in LSGs and parotid gland destruction (7, 8). Although we are not sure 
at present about the exact pathways in SS used by HTLV-I compared with SS that 
develops in anti-HTLV-I antibody-negative subjects, the present study is the first 
investigation in humans showing that HTLV-I infects into SGECs, impacting on 
inducing pathological condition of SS. 
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FIGURE LEGENDS 
 
Fig. 1. Characterization of HTLV-I-infected HCT-5 T cell line. 
A: After fixation in PBS containing 4% PFA at 4°C followed by immersion in 
methanol at −20°C for 10 min, HCT-5 cells were reacted with primary antibodies 
(anti-CD4, CD8, CD20, and mouse IgG1) followed by incubation with 
FITC-conjugated secondary antibody with Hoechst 33258 for counterstaining. B: 
HCT-5 for 0–96 h culture in keratinocyte-SFM were fixed and incubated with 
mouse anti-HTLV-I (p19, p28, and GAG) antibody and rabbit anti-NF-κB p65 
antibody and then reacted with FITC- and TRITC-conjugated secondary 
antibodies with Hoechst 33258 for counterstaining. Representative results of two 
independent experiments with similar findings are shown. 
 
Fig. 2. Detection of HTLV-I-related molecules in co-cultured SGECs. 
A: After the SGECs co-cultured for 0–96 h were fixed in PBS containing 4% 
PFA at 4°C followed by immersion in methanol at −20°C for 10 min, 
immunofluorescence was evaluated to detect the presence of HTLV-I proteins 
(p19, p28, and GAG). The SGECs were initially incubated with anti-HTLV-I 
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antibody and NF-κB p65 followed by FITC- and TRITC-conjugated secondary 
antibodies with Hoechst 33258 for counterstaining, respectively. In contrast to 
increased expression of HTLV-I proteins without NF-κB translocation (96h-a), 
the translocation of NF-κB is shown in a different view (96h-b). B: 
Low-magnification view at 96 h co-culture of SGECs with HCT-5 cells. C: After 
the SGECs co-cultured for 0–96 h were fixed and immersed, 
immunofluorescence was evaluated to show the presence of HTLV-I proteins 
(p19, p28, and GAG) and SGEC marker, cytokeratin 8/18. The SGECs were 
initially incubated with anti-HTLV-I antibody and anti-cytokeratin 8/18 antibody 
followed by FITC- and TRITC-conjugated secondary antibodies with Hoechst 
33258 for counterstaining, respectively. HTLV-I-infected SGECs were shown as 
yellow staining; meanwhile HCT-5 cells were indicated as green signal in 
merged view. Representative results of three independent experiments are shown. 
 
Fig. 3. Detection of HTLV-I proviral DNA by in situ PCR. 
A: For the positive control, HCT-5 cells were used after treatment with 1 µg/mL 
of PK, and five cycles of in situ PCR were performed. B: The fixed SGECs were 
treated with 1 µg/mL of PK, and five cycles of in situ PCR were then performed 
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in the presence and absence of primers for HTLV-I pX region as reported by 
Matsuoka et al. (17). Representative results of two independent experiments with 
similar findings are shown. 
 
Fig. 4. Semiquantitative analyses of inflammation-related molecules in the 
supernatant and apoptosis-related molecules in lysate during co-culture. 
A and C: Co-cultured supernatant was assayed with a human cytokine dot-blot 
array kit. Data at 0–96 h are shown as the semiquantitative concentration of each 
molecule in culture medium (i.e., keratinocyte SFM) for SGECs after co-culture 
with HCT-5 cells (A) or Jurkat (C). “HCT-5 only” and “Jurkat only” indicate the 
culture supernatant for HCT-5 and Jurkat, respectively. The expressions are noted 
as the ratio compared with control dot-blots. Representative results of two 
independent experiments with similar findings are shown. 
B and D: Co-cultured SGECs, HCT-5 lysate and Jurkat lysate was analyzed 
using a human apoptosis dot-blot array kit. Data at 0–96 h co-cultured with 
HCT-5 (B) and Jurkat (D) are shown as semiquantitative concentrations of each 
molecule in recovered SGECs lysate. “HCT-5 only” and “Jurkat only” indicate 
data from HCT-5 cell lysate and Jurkat lysate, respectively. The expressions are 
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presented as the ratio compared with control dot-blots. Representative results of 
two independent experiments with similar findings are shown. 
 
Fig. 5. Confirmation of the increase in the expression of 
inflammation-related molecules in co-culture by immunofluorescence and 
ELISA. 
A and B: The SGECs were co-cultured with HCT-5 (A) and Jurkat (B) for 96 h. 
The SGECs at 0 and 96 h were fixed in PBS containing 4% PFA at 4°C, followed 
by immersion in methanol at −20°C for 10 min, and then an immunofluorescence 
analysis was performed. The SGECs were incubated with anti-ICAM-1, CXCL-1, 
RANTES, IL-8 and IP-10 antibodies followed by FITC- and TRITC-conjugated 
secondary antibodies with Hoechst 33258 for counterstaining. Representative 
results of two independent experiments with similar findings are shown. 
C and D: The SGECs were co-cultured with HCT-5 (C) and Jurkat (D) for 0-96 
h. Then, ELISAs were performed using the co-cultured supernatant. The 
concentrations of sICAM-1, CXCL10/IP-10, CCR5/RANTES, CXCL1/GROα 
and CXCL8/IL-8 were detected by ELISA. Samples were collected from three 
independent patients, and the data shown are mean ± SD. *p<0.05 and **p<0.01 
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vs. 0 h (Student’s t-test). 
 
Fig. 6. Apoptosis of SGECs during co-culture with HCT-5 cells. 
A and B: The SGECs were co-cultured with HCT-5 (A) and Jurkat (B) for 96 h. 
After the SGECs at 0 and 96 h were fixed in PBS containing 4% PFA at 4°C 
followed by immersion in methanol at −20°C for 10 min, an immunofluorescence 
analysis was performed to reveal apoptosis-related molecules. The SGECs were 
incubated with anti-Bcl-2, Fas, cytochrome C (Cyt C), HO-2 and HSP-27 
antibodies followed by FITC-conjugated secondary antibody with Hoechst 33258 
for counterstaining. Representative results of two independent experiments with 
similar findings are shown. 
C and D: The SGECs were co-cultured with HCT-5 (C) and Jurkat (D) for 0-96 
h. The SGECs at 0–96 h were fixed in PBS containing 4% PFA at 4°C followed 
by immersion in methanol at −20°C for 10 min, then analyzed for TUNEL 
staining with Hoechst 33258 for nuclear staining. The FITC-conjugated green 
signal suggested the presence of TUNEL-positive cells. Before the TUNEL assay, 
observations in the bright field were also made. For the positive control (PC), the 
SGECs were treated with TRAIL for 3 h as reported previously (15). 
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